GEN Exclusives

More »

GEN News Highlights

More »
Jan 8, 2007

NimbleGen Licenses OGT’s Oligonucleotide Patents

  • NimbleGen Systems licensed Oxford Gene Technology’s (OGT) Southern array patents covering the manufacture and commercialization of oligonucleotide arrays. In addition, NimbleGen will be able to make and sell OGT-designed arrays, and OGT will obtain DNA microarrays from NimbleGen, under a supply agreement between the two firms.

    “Successful discussions with NimbleGen have concluded with the granting of this license thus enabling NimbleGen to deliver their microarray products and services worldwide and adding to OGT’s growing portfolio of North American licensees,” says Sue Sutton, vp licensing North America at OGT.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Cancer Drug Approvals and Efficacy

Do you think regulatory agencies should be required to provide stronger evidence of the clinical effectiveness of cancer drugs, including a greater emphasis on patient survival time?

More »